- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
Flu Research Moratorium Should Continue, Fauci Says
26 April 2012 5:36 pm
Although the contention over whether to publish two controversial H5N1 avian influenza studies appears to be waning, researchers should continue to abide by a voluntary moratorium on certain types of studies involving the virus, a senior U.S. science official said today.
There should be "an extension on the moratorium," which was originally supposed to expire on 20 March, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) told a U.S. Senate panel today. "The question is for how long."
The comments came at a hearing held by the Committee on Homeland Security and Governmental Affairs into the risk posed by "dual use" research that carries both benefits and risks. The hearing was prompted, in large part, by the H5N1 controversy, said Senator Joseph Lieberman (I-CT), the chair of the panel. "Although this particular issue appears to have been resolved, it's going to recur and we can't just 'kick this can down the road' and deal with it on an ad hoc basis when it happens again."
Four witnesses, including Fauci, discussed the process that led to a decision by the National Science Advisory Board for Biosecurity (NSABB) to support publication of the two papers, and new U.S. government rules designed to identify taxpayer-funded dual use research of concern before it begins. They also responded to criticism of the NSABB process by one of the panel's members, Michael Osterholm of the University of Minnesota, Twin Cities, in a letter first obtained by ScienceInsider.
Look for more details on the hearing tomorrow on ScienceInsider.